These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Zanamivir: from drug design to the clinic. Elliott M Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388 [TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110 [TBL] [Abstract][Full Text] [Related]
4. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
5. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ; N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672 [TBL] [Abstract][Full Text] [Related]
6. Two neuraminidase inhibitors for treatment of influenza. Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051 [No Abstract] [Full Text] [Related]
7. Neuraminidase inhibitors for influenza. Moscona A N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481 [No Abstract] [Full Text] [Related]
15. Oseltamivir resistance in influenza A (H5N1) infection. Gupta RK; Nguyen-Van-Tam JS N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors. Höffken G; Gillissen A Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza]. Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008 [TBL] [Abstract][Full Text] [Related]
18. The relentless flu drug. Environ Health Perspect; 1998 Aug; 106(8):A372-3. PubMed ID: 9867459 [No Abstract] [Full Text] [Related]
19. Zanamivir. No noticeable progress against influenza. Can Fam Physician; 2000 Oct; 46():2003-8, 2012-8. PubMed ID: 11184246 [TBL] [Abstract][Full Text] [Related]
20. [Zanamivir: new therapeutic option for influenza]. Caballero E; Prieto C; Ruiz M; Azanza JR Rev Med Univ Navarra; 2000; 44(1):56-61. PubMed ID: 11002900 [No Abstract] [Full Text] [Related] [Next] [New Search]